Reported Reactions

Devices › Device types

FDA product code QFG · class 2 · Clinical Chemistry

Alternate controller enabled insulin infusion pump: medical device reports filed with FDA

1,297,995 reports carry this product code, 2020–2026; 30 brands with a page.

1,297,995
reports with this product code
5% of all MAUDE reports
400,824
reports, 12 months to August 2026
295,187 in the 12 months before
88.9%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code QFG is FDA's classification for "Alternate controller enabled insulin infusion pump" (clinical Chemistry panel), a class 2 device. 1,297,995 medical device reports carry this product code, 5% of the MAUDE database, from January 2020 to August 2026.

400,824 reports arrived in the 12 months to August 2026, up 36% from 295,187 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88.9%) and injury (11.1%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
t:slim X2 Insulin Pump with Control-IQ Technology584,157129,1190%90.6%
t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)267,58411,5020%90.3%
Omnipod 5 Pod72,51413,9130.1%85.9%
t:slim X2 Insulin Pump with Control-IQ+ Technology65,29857,9360%86.2%
iLet Bionic Pancreas62,86360,7710.1%76.4%
Omnipod 5 Pods53,25334,5930%92.2%
Omnipod 5 Automated Insulin Delivery System50,52332,4780%94%
t:slim X2 Insulin Pump with Interoperable Technology37,0728650%88.3%
Tandem Mobi Insulin Pump with Control-IQ+ Technology36,50631,6740%83.1%
Tandem Mobi Insulin Pump with Interoperable Technology27,9511,5950%87.8%
Tandem Mobi Insulin Pump with Control-IQ Technology15,1549,5530%85%
MiniMed 780G US System BLE Connect 3.0 mg/dL11,19757,1400.1%75.5%
t:slim X2 Insulin Pump with Basal-IQ Technology3,3511,9160%90.8%
Omnipod 5 Controller2,6149260.8%53.3%
T Slim X2 Insulin Pump With Interoperable Technology With T Connect Mobile A2,53600%85%
PUMP MMT-1884L MM780G BLE 3.0 mg/ml1,1749,7030.1%81.1%
T Slim X2 Insulin Pump With Interoperable Technology With T Connect Mobile Ap45200%81.7%
Tandem Mobi Mobile App4433400%91.9%
T Slim X2 With Basal-Iq Technology39200%91.3%
T Slim X2 Insulin Pump With Control-Iq Technology With T Connect Mobile App29600%93.6%
twiist Automated Insulin Delivery System2782770.4%42.4%
Omnipod 52411640.8%44.3%
T Slim X2 Insulin Pump With Interoperable Technology With T Connect Mobi18300%94%
Ilet Bionic Pancreas - Ta000036-00115650%30.8%
t:slim X2 Insulin Pump19860%81.9%
Pump Mmt-1884g 780g 6 21 Gs181460%88.3%
Omnipod DASH Insulin Management System95,5630.1%90.9%
OmniPod Insulin Pump61450.3%75.5%
T Slim X2 Basal-Iq Mmol/L300%93.8%
Tandem T Slim Insulin Delivery System300.1%65.2%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Tandem Diabetes Care1,042,45580.3%
Insulet179,53813.8%
Beta Bionics62,3214.8%
Medtronic Puerto Rico Operations12,3981%
Medtronic Minimed1510%
Dexcom180%

Reports by month, five years

019,78339,565Sep 2021: 6,237Oct 2021: 6,396Nov 2021: 8,441Dec 2021: 8,8542022Jan 2022: 7,212Feb 2022: 8,358Mar 2022: 9,180Apr 2022: 9,927May 2022: 9,513Jun 2022: 11,279Jul 2022: 10,769Aug 2022: 12,795Sep 2022: 11,004Oct 2022: 12,169Nov 2022: 12,578Dec 2022: 14,3352023Jan 2023: 12,973Feb 2023: 13,784Mar 2023: 16,428Apr 2023: 14,131May 2023: 15,744Jun 2023: 15,947Jul 2023: 14,636Aug 2023: 18,106Sep 2023: 15,747Oct 2023: 17,001Nov 2023: 16,858Dec 2023: 16,6592024Jan 2024: 17,933Feb 2024: 16,847Mar 2024: 21,353Apr 2024: 22,901May 2024: 22,743Jun 2024: 19,469Jul 2024: 29,221Aug 2024: 29,161Sep 2024: 23,980Oct 2024: 25,877Nov 2024: 20,050Dec 2024: 23,6552025Jan 2025: 28,108Feb 2025: 19,813Mar 2025: 23,190Apr 2025: 24,631May 2025: 23,786Jun 2025: 21,879Jul 2025: 32,410Aug 2025: 27,808Sep 2025: 29,932Oct 2025: 31,488Nov 2025: 28,190Dec 2025: 37,0052026Jan 2026: 31,716Feb 2026: 32,688Mar 2026: 32,799Apr 2026: 33,224May 2026: 31,940Jun 2026: 35,112Jul 2026: 39,565Aug 2026: 37,165

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%348
Injury11.1%143,822
Malfunction88.9%1,153,773
Other0%49
Not given0%3

Who filed

Manufacturer report99.9%1,297,255
Voluntary report0.1%739
User facility report0%0
Distributor report0%0
Not given0%1

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Pumping stopped351,86927.1%
Charging problem95,9797.4%
Incorrect measurementthe device measured wrongly87,9046.8%
Unintended movement85,9896.6%
Obstruction of flow82,8156.4%
Loss of or failure to bond78,7696.1%
Battery problema problem with the battery68,2625.3%
Communication or transmission problemthe device could not communicate or transmit60,6784.7%
Failure to sense42,2573.3%
Insufficient device problem information41,9823.2%
Mechanical problema mechanical problem36,1702.8%
Material twisted/bent35,3412.7%
Filling problem31,7762.4%
False alarm30,7872.4%
Crackthe device cracked25,4302%
Failure to charge24,9431.9%
Fluid/blood leak20,6551.6%
Device sensing problem20,6441.6%
Poor quality image20,0261.5%
Key or button unresponsive/not working18,1551.4%

Questions about alternate controller enabled insulin infusion pump reports

What is product code QFG?

FDA's classification code for "Alternate controller enabled insulin infusion pump", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.

How many reports carry this code?

1,297,995 reports through August 2026, 400,824 of them in the latest 12 months.

Which brands appear most often?

t:slim X2 Insulin Pump with Control-IQ Technology (584,157), t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app) (267,584), Omnipod 5 Pod (72,514), t:slim X2 Insulin Pump with Control-IQ+ Technology (65,298) and iLet Bionic Pancreas (62,863). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.